CMS entrusts overseas pharmaceutical manufacturers to produce imported products, while some of its domestic products are produced by the Group’s own manufacturing plants.

The Group has pharmaceutical manufacturing sites in Hunan, Hebei and Shenzhen, occupying a total area of more than 110,000 square meters. The Group has the Pharmaceutical Production Licenses and the Pharmaceutical GMP Certificates for various dosage forms such as powder, oral solution, small-volume injections, tablets, hard capsules, etc., and instituted stringent quality management standards and regulations to guarantee the product quality.

Leveraging its production experiences for over two decades as well as its mature manufacturing quality control system, the Group expects to realize the localized preparation manufacturing for some overseas innovative products through the technology transfer, and submit new drug application and obtain marketing approval as Category 1 new drugs.